• Cimeio Therapeutics AG

    BS
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-280.3.024.812-1
    Sector: Research and development

    Age of the company

    5 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    638'062

    Employees

    PremiumPremium

    Active brands

    0

    Reports for Cimeio Therapeutics AG

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Cimeio Therapeutics AG

    • Cimeio Therapeutics AG with its legal headquarters in Basel is active. Cimeio Therapeutics AG operates in the sector «Research and development».
    • The management consists of 6 persons. The company was founded on 29.07.2020.
    • On the 30.04.2025 the commercial register entry of the company was last changed. Under «Notifications» you will find all changes.
    • The UID registered in the commercial register of BS is CHE-465.367.689.
    • Companies with an identical address: AlpENa Biosciences AG, Basel Tourismus, Boutique Danoise AG.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Die Gesellschaft bezweckt die Entwicklung, die Produktion und den Vertrieb von pharmazeutischen und immunopharmazeutischen Produkten sowie die Erbringung damit im Zusammenhang stehenden Dienstleistungen. Die Gesellschaft kann sich daneben an anderen Unternehmen irgendwelcher Art im In- und Ausland beteiligen, solche gründen, übernehmen und mit ihnen fusionieren. Sie kann Liegenschaften und Immaterialgüterrechte im In- und Ausland erwerben, belasten und veräussern sowie durch Beschluss des Verwaltungsrates Zweigniederlassungen und Agenturen im In- oder Ausland errichten.

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    Ernst & Young AG
    Basel 23.07.2024

    Would you like to adjust the auditors? Click here.

    Former auditor (1)
    Name City Since Until
    KPMG AG
    Basel 27.01.2023 22.07.2024

    Other company names

    Source: SOGC

    Past and translated company names

    • Cimeio Therapeutics Ltd
    • Cimeio Therapeutics SA
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Cimeio Therapeutics AG

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250430/2025 - 30.04.2025
    Categories: Change in management

    Publication number: HR02-1006320428, Commercial Registry Office Basel-Stadt, (270)

    Cimeio Therapeutics AG, in Basel, CHE-465.367.689, Aktiengesellschaft (SHAB Nr. 253 vom 31.12.2024, Publ. 1006219620).

    Ausgeschiedene Personen und erloschene Unterschriften:
    Santarelli, Luca, italienischer Staatsangehöriger, in Basel, Mitglied des Verwaltungsrates, mit Kollektivunterschrift zu zweien.

    SOGC 241231/2024 - 31.12.2024
    Categories: Change in management

    Publication number: HR02-1006219620, Commercial Registry Office Basel-Stadt, (270)

    Cimeio Therapeutics AG, in Basel, CHE-465.367.689, Aktiengesellschaft (SHAB Nr. 141 vom 23.07.2024, Publ. 1006091553).

    Ausgeschiedene Personen und erloschene Unterschriften:
    Fuchs, Thomas Henry, amerikanischer Staatsangehöriger, in Basel, mit Kollektivunterschrift zu zweien;
    Maurer, Cornelia, von Schmiedrued, in Küttigen, mit Kollektivunterschrift zu zweien.

    SOGC 240723/2024 - 23.07.2024
    Categories: Change of auditors

    Publication number: HR02-1006091553, Commercial Registry Office Basel-Stadt, (270)

    Cimeio Therapeutics AG, in Basel, CHE-465.367.689, Aktiengesellschaft (SHAB Nr. 103 vom 30.05.2024, Publ. 1006043912).

    Ausgeschiedene Personen und erloschene Unterschriften:
    KPMG AG (CHE-154.017.048), in Basel, Revisionsstelle.

    Eingetragene Personen neu oder mutierend:
    Ernst & Young AG (CHE-105.932.265), in Basel, Revisionsstelle.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm